Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-90 a Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev

Journal of Thoracic Oncology

English

MA13.11 Photodynamic Therapy for Peripheral-Type Lung Cancer in a Multi-Center Clinical Trial

Journal of Thoracic Oncology

English

P206 Psychological Comorbidity in Vocal Cord Dysfunction

English

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

Journal of Thoracic Oncology

English

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

Journal of Thoracic Oncology

English

MTE28.01 Lessons From the Past-What I Would Not Do Again in Diagnostic and Therapeutic IP

Journal of Thoracic Oncology

English

P3.01-82 Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Journal of Thoracic Oncology

English

MA17.09 Remote Symptom Reporting for Tele-Nursing Team in Thoracic Oncology Clinics: Environmental Scan and Stakeholder Engagement

Journal of Thoracic Oncology

English

P2.04-06 Increased Plasma Cell % and Decreased B-Cells in Tumor Immune Infiltrates Are Associated With Worse Prognosis in Lung Adenocarcinomas

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-90 a Phase II Study Evaluating Continuation of EGFR-TKIs Beyond Progressive Disease Followed by the Addition of CDDP+PEM+Bev

MA13.11 Photodynamic Therapy for Peripheral-Type Lung Cancer in a Multi-Center Clinical Trial

P206 Psychological Comorbidity in Vocal Cord Dysfunction

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

MTE28.01 Lessons From the Past-What I Would Not Do Again in Diagnostic and Therapeutic IP

P3.01-82 Survival Impact of Surgery in the Treatment of Stage IIIB-IVA Non-Small Cell Lung Cancer

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

MA17.09 Remote Symptom Reporting for Tele-Nursing Team in Thoracic Oncology Clinics: Environmental Scan and Stakeholder Engagement

P2.04-06 Increased Plasma Cell % and Decreased B-Cells in Tumor Immune Infiltrates Are Associated With Worse Prognosis in Lung Adenocarcinomas